— Know what they know.
Not Investment Advice
Also trades as: 0R2S.L (LSE) · $vol 2M · SYK.DE (XETRA) · $vol 0M

SYK NYSE

Stryker Corporation
1W: +2.6% 1M: -4.8% 3M: -17.5% YTD: -9.9% 1Y: -19.2% 3Y: +12.3% 5Y: +29.9%
$316.48
+2.98 (+0.95%)
 
Weekly Expected Move ±5.1%
$275 $291 $307 $322 $338
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 56 · $121.3B mcap · 347M float · 0.657% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
64.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 11.8%  ·  5Y Avg: 10.1%
Cost Advantage
79
Intangibles
51
Switching Cost
64
Network Effect
55
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SYK has a Narrow competitive edge (64.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 11.8% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$315
Low
$372
Avg Target
$418
High
Based on 9 analysts since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 35Hold: 14Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$382.91
Analysts11
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-04 Truist Financial Richard Newitter $400 $330 -70 +12.5% $293.44
2026-05-04 Barclays Matt Miksic $469 $394 -75 +33.7% $294.73
2026-05-01 Goldman Sachs David Roman $399 $361 -38 +22.5% $294.73
2026-05-01 Bernstein $465 $410 -55 +35.6% $302.38
2026-05-01 Robert W. Baird $437 $385 -52 +25.1% $307.87
2026-05-01 Evercore ISI $390 $355 -35 +15.2% $308.17
2026-05-01 BTIG $412 $379 -33 +20.2% $315.18
2026-05-01 Needham $454 $418 -36 +32.6% $315.18
2026-05-01 Deutsche Bank $285 $315 +30 -0.1% $315.18
2026-03-04 Jefferies Matthew Taylor Initiated $465 +21.8% $381.89
2026-02-24 UBS $408 $400 -8 +4.8% $381.83
2026-02-02 Barclays $257 $469 +212 +26.9% $369.56
2026-01-30 Needham Mike Matson $448 $454 +6 +24.2% $365.62
2026-01-30 Robert W. Baird Initiated $437 +18.4% $369.02
2026-01-30 BTIG Ryan Zimmerman $403 $412 +9 +16.3% $354.30
2026-01-09 Bernstein Lee Hambright $450 $465 +15 +26.6% $367.21
2026-01-09 Goldman Sachs $422 $399 -23 +8.7% $367.21
2026-01-06 Raymond James Initiated $418 +19.8% $348.79
2026-01-05 Evercore ISI $405 $390 -15 +12.2% $347.69
2025-11-14 Truist Financial Richard Newitter $392 $400 +8 +9.2% $366.38
2025-11-14 RBC Capital Shagun Singh $272 $435 +163 +19.1% $365.14
2025-11-14 Needham Mike Matson $392 $448 +56 +20.0% $373.42
2025-11-03 Truist Financial $407 $392 -15 +9.1% $359.36
2025-10-31 Evercore ISI $410 $405 -5 +13.3% $357.60
2025-10-15 Truist Financial $415 $407 -8 +9.7% $370.88
2025-10-13 UBS $267 $408 +141 +11.9% $364.60
2025-10-07 Evercore ISI Initiated $410 +11.9% $366.28
2025-09-18 Redburn Partners Initiated $420 +11.5% $376.80
2025-08-04 Truist Financial $409 $415 +6 +8.8% $381.49
2025-05-05 Bernstein Lee Hambright $295 $450 +155 +18.0% $381.36
2025-04-14 BTIG Ryan Zimmerman $394 $403 +9 +14.0% $353.42
2025-03-04 Goldman Sachs $372 $422 +50 +8.2% $389.92
2025-02-03 Argus Research David Toung $380 $450 +70 +15.0% $391.14
2024-12-18 Truist Financial Richard Newitter $380 $409 +29 +13.9% $359.17
2024-12-02 Morgan Stanley Patrick Wood $260 $445 +185 +13.8% $390.90
2024-10-31 Citigroup Joanne Wuensch Initiated $411 +13.1% $363.43
2024-10-30 Piper Sandler Matt O'Brien $380 $420 +40 +14.1% $367.95
2024-10-30 Truist Financial Richard Newitter $370 $380 +10 +4.0% $365.42
2024-10-30 Canaccord Genuity Kyle Rose $290 $400 +110 +11.4% $359.01
2024-10-30 BTIG Ryan Zimmerman $374 $394 +20 +9.7% $359.01
2024-10-14 Truist Financial Richard Newitter $345 $370 +25 +3.8% $356.45
2024-09-10 Piper Sandler Matt O\'Brien $280 $380 +100 +4.0% $365.22
2024-08-28 BTIG Ryan Zimmerman $360 $374 +14 +4.3% $358.51
2024-08-01 Truist Financial Richard Newitter $280 $345 +65 +5.5% $327.00
2024-07-31 BTIG Ryan Zimmerman $366 $360 -6 +9.0% $330.22
2024-05-30 Goldman Sachs David Roman Initiated $372 +9.0% $341.14
2024-05-22 Argus Research David Toung $270 $380 +110 +15.0% $330.51
2024-05-22 Needham Mike Matson Initiated $392 +18.6% $330.51
2024-04-15 BTIG Ryan Zimmerman $268 $366 +98 +7.0% $342.05
2023-01-31 Piper Sandler Matt O'Brien $260 $280 +20 +10.3% $253.81

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
4
ROE
4
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SYK receives an overall rating of B. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-04 B+ B
2026-04-30 B B+
2026-03-24 B- B
2026-01-03 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

68 Grade A
Profitability
58
Balance Sheet
61
Earnings Quality
75
Growth
58
Value
40
Momentum
85
Safety
100
Cash Flow
73
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SYK scores highest in Safety (100/100) and lowest in Value (40/100). An overall grade of A places SYK among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.03
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
-2.61
Unlikely Manipulator
Ohlson O-Score
-8.88
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 79.0/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.61x
Accruals: -4.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SYK scores 4.03, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SYK scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SYK's score of -2.61 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SYK's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SYK receives an estimated rating of A+ (score: 79.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SYK's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
36.31x
PEG
2.21x
P/S
4.80x
P/B
5.43x
P/FCF
27.78x
P/OCF
23.63x
EV/EBITDA
23.82x
EV/Revenue
5.45x
EV/EBIT
28.38x
EV/FCF
30.14x
Earnings Yield
2.63%
FCF Yield
3.60%
Shareholder Yield
1.05%
Graham Number
$106.15
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 36.3x earnings, SYK commands a growth premium. Graham's intrinsic value formula yields $106.15 per share, 198% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.725
NI / EBT
×
Interest Burden
0.948
EBT / EBIT
×
EBIT Margin
0.192
EBIT / Rev
×
Asset Turnover
0.557
Rev / Assets
×
Equity Multiplier
2.109
Assets / Equity
=
ROE
15.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SYK's ROE of 15.5% is driven by Asset Turnover (0.557), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
7.99%
Fair P/E
24.48x
Intrinsic Value
$211.39
Price/Value
1.55x
Margin of Safety
-55.44%
Premium
55.44%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SYK's realized 8.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $211.39, SYK appears undervalued with a -55% margin of safety. The adjusted fair P/E of 24.5x compares to the current market P/E of 36.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$316.44
Median 1Y
$328.39
5th Pctile
$206.78
95th Pctile
$521.23
Ann. Volatility
28.4%
Analyst Target
$382.91
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kevin A. Lobo
Chair, Chief Executive Officer and President
$1,491,667 $9,764,136 $21,401,495
Spencer S. Stiles
Group President, Orthopaedics
$792,500 $2,685,078 $6,328,959
J. Andrew Pierce
Group President, MedSurg and Neurotechnology
$792,500 $2,685,078 $6,323,107
Preston W. Wells
Vice President, Chief Financial Officer
$653,431 $1,841,377 $4,410,422
Viju S. Menon
Group President, Global Quality and Operations
$675,000 $1,647,444 $4,235,809
Glenn S. Boehnlein
Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer
$800,000 $— $1,893,046

CEO Pay Ratio

139:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $21,401,495
Avg Employee Cost (SGA/emp): $154,482
Employees: 56,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
56,000
+5.7% YoY
Revenue / Employee
$448,500
Rev: $25,116,000,000
Profit / Employee
$57,964
NI: $3,246,000,000
SGA / Employee
$154,482
Avg labor cost proxy
R&D / Employee
$28,250
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 16.1% 14.7% 14.3% 14.4% 14.9% 17.6% 15.0% 16.7% 17.2% 16.4% 18.0% 19.1% 19.6% 20.4% 15.3% 14.6% 14.9% 15.0% 15.1% 15.5% 15.50%
ROA 6.5% 5.9% 5.8% 5.8% 6.0% 7.1% 6.6% 7.3% 7.6% 7.2% 8.2% 8.8% 9.0% 9.3% 7.2% 6.9% 7.0% 7.1% 7.1% 7.3% 7.35%
ROIC 12.6% 12.9% 12.9% 13.1% 13.1% 13.4% 11.6% 11.9% 12.1% 11.7% 12.9% 13.2% 13.5% 14.1% 14.3% 14.8% 15.6% 15.6% 12.2% 11.8% 11.79%
ROCE 8.5% 7.5% 8.7% 8.8% 8.9% 10.0% 8.8% 9.7% 10.3% 10.5% 11.5% 12.2% 12.6% 13.1% 9.9% 9.4% 9.9% 9.9% 11.7% 12.1% 12.12%
Gross Margin 62.5% 63.0% 62.3% 60.6% 59.8% 59.2% 59.1% 60.1% 60.8% 61.5% 61.1% 60.9% 61.3% 61.8% 62.0% 62.7% 62.3% 63.6% 65.2% 63.3% 63.29%
Operating Margin 21.8% 21.5% 23.2% 18.3% 20.2% 19.0% 23.0% 18.0% 21.3% 20.2% 24.5% 19.1% 21.4% 22.0% 25.8% 20.1% 22.6% 18.7% 27.3% 15.5% 15.55%
Net Margin 13.8% 10.5% 14.1% 7.6% 14.6% 18.2% 10.8% 12.4% 14.8% 14.1% 19.7% 15.0% 15.2% 15.2% 8.5% 11.1% 14.7% 14.2% 11.8% 12.4% 12.38%
EBITDA Margin 21.0% 17.5% 28.3% 14.7% 21.7% 23.8% 19.5% 19.6% 23.2% 23.0% 25.4% 22.6% 23.2% 23.9% 12.3% 17.7% 24.4% 22.5% 23.9% 20.5% 20.53%
FCF Margin 18.3% 18.1% 16.0% 14.1% 11.7% 11.2% 11.0% 12.0% 12.4% 12.9% 15.3% 13.6% 13.1% 14.6% 15.4% 15.4% 16.9% 16.7% 17.1% 18.1% 18.09%
OCF Margin 20.9% 21.0% 19.1% 17.3% 15.1% 14.6% 14.2% 15.1% 15.5% 16.0% 18.1% 16.6% 16.0% 17.5% 18.8% 18.5% 20.0% 19.8% 20.1% 21.3% 21.27%
ROE 3Y Avg snapshot only 15.61%
ROE 5Y Avg snapshot only 15.23%
ROA 3Y Avg snapshot only 7.35%
ROIC 3Y Avg snapshot only 9.00%
ROIC Economic snapshot only 10.64%
Cash ROA snapshot only 11.23%
Cash ROIC snapshot only 16.20%
CROIC snapshot only 13.78%
NOPAT Margin snapshot only 15.48%
Pretax Margin snapshot only 18.20%
R&D / Revenue snapshot only 6.41%
SGA / Revenue snapshot only 33.82%
SBC / Revenue snapshot only 0.44%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 45.61 50.94 49.35 48.95 35.38 30.55 38.60 40.66 42.32 39.85 35.75 40.45 37.61 38.45 46.14 50.09 52.27 48.57 41.85 38.06 36.314
P/S Ratio 5.85 5.81 5.75 5.66 4.17 4.18 4.93 5.64 5.89 5.18 5.52 6.49 6.06 6.28 6.11 6.17 6.40 5.86 5.41 5.03 4.801
P/B Ratio 7.26 7.40 6.61 6.63 4.94 5.05 5.48 6.43 6.90 6.20 6.09 7.31 6.97 7.42 6.69 6.94 7.39 6.93 6.06 5.66 5.435
P/FCF 31.96 32.09 35.94 40.21 35.58 37.25 44.70 47.11 47.43 40.11 36.08 47.57 46.26 43.07 39.60 40.03 37.90 35.10 31.72 27.78 27.784
P/OCF 27.98 27.65 30.16 32.73 27.60 28.64 34.69 37.27 37.90 32.33 30.49 39.18 37.97 35.96 32.55 33.40 32.00 29.58 26.93 23.63 23.628
EV/EBITDA 31.13 34.13 30.04 30.23 22.80 21.26 27.88 29.68 30.24 27.03 26.29 29.59 27.77 28.41 32.52 34.77 35.17 32.73 26.25 23.82 23.817
EV/Revenue 6.55 6.49 6.33 6.23 4.73 4.73 5.56 6.25 6.49 5.76 6.03 6.98 6.55 6.76 6.54 6.58 6.81 6.26 5.84 5.45 5.451
EV/EBIT 42.91 49.29 41.41 41.20 30.99 28.19 38.25 39.79 40.01 35.72 33.65 37.37 34.89 35.44 42.30 45.85 46.20 43.64 31.31 28.38 28.381
EV/FCF 35.79 35.87 39.55 44.24 40.36 42.16 50.40 52.23 52.23 44.63 39.41 51.22 49.98 46.33 42.36 42.73 40.30 37.46 34.23 30.14 30.138
Earnings Yield 2.2% 2.0% 2.0% 2.0% 2.8% 3.3% 2.6% 2.5% 2.4% 2.5% 2.8% 2.5% 2.7% 2.6% 2.2% 2.0% 1.9% 2.1% 2.4% 2.6% 2.63%
FCF Yield 3.1% 3.1% 2.8% 2.5% 2.8% 2.7% 2.2% 2.1% 2.1% 2.5% 2.8% 2.1% 2.2% 2.3% 2.5% 2.5% 2.6% 2.8% 3.2% 3.6% 3.60%
PEG Ratio snapshot only 2.214
EV/OCF snapshot only 25.630
EV/Gross Profit snapshot only 8.562
Acquirers Multiple snapshot only 25.544
Shareholder Yield snapshot only 1.05%
Graham Number snapshot only $106.15
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.93 1.93 2.20 2.20 2.20 2.20 1.63 1.63 1.63 1.63 1.58 1.58 1.58 1.58 1.95 1.95 1.95 1.95 1.89 1.89 1.893
Quick Ratio 1.23 1.23 1.47 1.47 1.47 1.47 1.00 1.00 1.00 1.00 0.97 0.97 0.97 0.97 1.32 1.32 1.32 1.32 1.21 1.21 1.212
Debt/Equity 1.10 1.10 0.87 0.87 0.87 0.87 0.81 0.81 0.81 0.81 0.73 0.73 0.73 0.73 0.68 0.68 0.68 0.68 0.66 0.66 0.663
Net Debt/Equity 0.87 0.87 0.66 0.66 0.66 0.66 0.70 0.70 0.70 0.70 0.56 0.56 0.56 0.56 0.47 0.47 0.47 0.47 0.48 0.48 0.480
Debt/Assets 0.42 0.42 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.34 0.34 0.34 0.34 0.33 0.33 0.33 0.33 0.31 0.31 0.311
Debt/EBITDA 4.22 4.55 3.58 3.59 3.52 3.23 3.67 3.39 3.24 3.19 2.87 2.73 2.67 2.58 3.11 3.21 3.06 3.03 2.66 2.57 2.569
Net Debt/EBITDA 3.34 3.60 2.74 2.75 2.70 2.47 3.15 2.91 2.78 2.74 2.22 2.11 2.07 2.00 2.12 2.19 2.09 2.06 1.93 1.86 1.860
Interest Coverage 22.08 11.06 6.72 5.74 5.744
Equity Multiplier 2.62 2.62 2.33 2.33 2.33 2.33 2.22 2.22 2.22 2.22 2.15 2.15 2.15 2.15 2.08 2.08 2.08 2.08 2.13 2.13 2.134
Cash Ratio snapshot only 0.526
Debt Service Coverage snapshot only 6.845
Cash to Debt snapshot only 0.276
FCF to Debt snapshot only 0.308
Defensive Interval snapshot only 277.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.50 0.52 0.50 0.51 0.51 0.52 0.52 0.53 0.54 0.56 0.53 0.55 0.56 0.57 0.55 0.56 0.57 0.59 0.55 0.56 0.557
Inventory Turnover 1.82 1.86 1.90 1.94 2.00 2.08 2.04 2.10 2.14 2.16 1.81 1.85 1.88 1.93 1.81 1.84 1.87 1.89 1.82 1.82 1.821
Receivables Turnover 5.81 5.96 5.98 6.09 6.16 6.27 5.60 5.75 5.91 6.04 5.59 5.72 5.84 6.00 5.83 5.99 6.14 6.29 6.26 6.30 6.297
Payables Turnover 8.30 8.51 6.67 6.81 7.02 7.32 5.86 6.04 6.16 6.20 5.47 5.57 5.66 5.81 5.44 5.53 5.64 5.70 10.91 10.94 10.936
DSO 63 61 61 60 59 58 65 63 62 60 65 64 63 61 63 61 59 58 58 58 58.0 days
DIO 201 196 192 188 183 175 179 174 170 169 201 198 194 190 202 199 195 193 201 200 200.4 days
DPO 44 43 55 54 52 50 62 60 59 59 67 66 64 63 67 66 65 64 33 33 33.4 days
Cash Conversion Cycle 219 214 198 194 190 183 182 177 173 171 200 196 192 188 197 194 190 187 226 225 225.0 days
Fixed Asset Turnover snapshot only 6.520
Operating Cycle snapshot only 258.4 days
Cash Velocity snapshot only 6.163
Capital Intensity snapshot only 1.893
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 15.5% 17.2% 19.2% 18.4% 8.5% 7.7% 7.8% 8.7% 10.4% 10.8% 11.1% 10.6% 9.9% 10.5% 10.2% 10.8% 11.4% 11.0% 11.2% 8.8% 8.84%
Net Income 30.1% 8.2% 24.7% 43.1% -0.2% 29.3% 18.3% 30.4% 30.3% 5.2% 34.2% 27.9% 27.3% 38.9% -5.4% -14.9% -15.4% -18.0% 8.5% 16.7% 16.72%
EPS 27.8% 7.5% 24.2% 42.7% -0.2% 29.6% 18.4% 30.2% 29.7% 4.6% 33.7% 27.3% 26.8% 38.3% -6.0% -15.2% -15.6% -18.3% 8.3% 16.7% 16.69%
FCF 51.7% 33.8% -1.9% -9.6% -30.5% -33.2% -25.6% -7.6% 16.9% 27.4% 54.0% 26.1% 16.0% 24.8% 11.2% 25.2% 43.6% 27.1% 22.8% 27.8% 27.79%
EBITDA 22.1% 5.6% 30.3% 37.0% 7.1% 26.1% 2.1% 11.1% 14.0% 6.1% 27.7% 24.0% 20.9% 23.3% -3.4% -11.2% -8.6% -10.8% 22.9% 31.6% 31.60%
Op. Income 35.7% 27.1% 24.3% 25.6% -0.1% -0.8% 2.3% 2.7% 7.9% 13.2% 16.2% 17.7% 15.4% 16.7% 16.0% 16.2% 18.2% 11.3% 12.0% 3.6% 3.55%
OCF Growth snapshot only 25.35%
Asset Growth snapshot only 11.34%
Equity Growth snapshot only 8.66%
Debt Growth snapshot only 5.23%
Shares Change snapshot only 0.03%
Dividend Growth snapshot only 5.34%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 7.6% 7.9% 7.9% 7.9% 7.5% 7.2% 7.4% 8.2% 11.4% 11.8% 12.6% 12.5% 9.6% 9.6% 9.7% 10.0% 10.6% 10.8% 10.8% 10.1% 10.07%
Revenue 5Y 9.2% 8.9% 8.6% 8.1% 8.1% 8.2% 8.2% 8.3% 8.3% 8.4% 8.5% 8.6% 8.5% 8.6% 8.7% 9.2% 11.1% 11.4% 11.8% 11.4% 11.42%
EPS 3Y 24.2% 15.2% -17.7% -17.2% -16.5% -10.6% 4.0% 6.4% 18.3% 13.4% 25.3% 33.3% 18.0% 23.3% 14.2% 12.0% 11.6% 5.8% 10.8% 8.0% 7.99%
EPS 5Y 5.1% 2.6% 3.7% 3.4% 4.0% 6.6% 18.2% 20.7% 20.0% 15.7% -2.5% -1.2% -0.9% 0.7% 7.2% 5.4% 12.1% 10.5% 14.9% 18.5% 18.54%
Net Income 3Y 24.5% 15.4% -17.5% -17.0% -16.3% -10.5% 4.2% 6.7% 19.2% 13.8% 25.6% 33.6% 18.3% 23.6% 14.5% 12.4% 12.0% 6.2% 11.2% 8.3% 8.30%
Net Income 5Y 5.4% 2.7% 3.9% 3.6% 4.1% 6.7% 18.2% 20.9% 20.2% 15.9% -2.3% -0.9% -0.6% 0.9% 7.5% 5.7% 12.8% 10.9% 15.2% 18.8% 18.84%
EBITDA 3Y 5.5% 1.9% 5.8% 6.3% 7.5% 10.0% 3.3% 4.9% 14.2% 12.2% 19.3% 23.6% 13.9% 18.1% 8.0% 7.0% 8.0% 5.3% 14.9% 13.2% 13.18%
EBITDA 5Y 3.6% 2.7% 5.8% 5.7% 7.4% 8.8% 6.9% 8.1% 7.5% 7.2% 9.1% 10.6% 11.4% 11.7% 6.3% 4.9% 10.5% 9.2% 15.1% 17.2% 17.15%
Gross Profit 3Y 7.3% 7.6% 7.6% 7.7% 7.0% 6.4% 5.9% 6.6% 11.1% 11.6% 13.0% 13.2% 9.1% 9.2% 9.3% 10.0% 11.0% 12.1% 13.2% 12.6% 12.57%
Gross Profit 5Y 7.6% 7.7% 7.7% 7.6% 7.4% 7.2% 7.1% 7.2% 7.4% 7.6% 7.9% 8.1% 8.2% 8.4% 8.4% 9.1% 11.8% 12.1% 13.1% 12.7% 12.74%
Op. Income 3Y 9.1% 8.1% 6.2% 6.3% 5.2% 4.1% 3.8% 4.6% 13.5% 12.6% 13.9% 15.0% 7.5% 9.4% 11.3% 12.0% 13.8% 13.7% 14.7% 12.3% 12.30%
Op. Income 5Y 12.5% 9.9% 9.1% 8.5% 7.1% 6.7% 6.9% 6.8% 6.9% 7.2% 7.3% 7.8% 7.7% 8.3% 8.5% 9.4% 14.8% 13.2% 13.9% 12.8% 12.82%
FCF 3Y 39.4% 22.5% 10.3% 6.1% 2.7% 2.0% 9.7% 8.0% 7.2% 4.4% 4.0% 1.8% -1.9% 2.0% 8.4% 13.4% 24.9% 26.4% 28.1% 26.3% 26.33%
FCF 5Y 44.4% 16.0% 15.2% 14.1% 7.9% 15.7% 16.2% 15.0% 17.1% 9.4% 9.0% 6.8% 8.0% 11.0% 17.7% 14.7% 15.5% 12.6% 9.0% 11.0% 11.01%
OCF 3Y 25.8% 16.0% 7.7% 4.7% 2.3% 1.6% 6.2% 5.1% 5.5% 4.7% 4.2% 3.4% 0.2% 3.1% 9.1% 12.5% 21.4% 22.6% 24.3% 23.3% 23.32%
OCF 5Y 31.7% 13.5% 12.2% 11.0% 6.5% 11.4% 11.0% 10.9% 12.2% 7.3% 7.3% 5.7% 6.5% 8.9% 14.1% 11.7% 13.1% 11.7% 9.0% 11.4% 11.36%
Assets 3Y 15.7% 15.7% 8.3% 8.3% 8.3% 8.3% 6.9% 6.9% 6.9% 6.9% 5.2% 5.2% 5.2% 5.2% 7.5% 7.5% 7.5% 7.5% 9.1% 9.1% 9.06%
Assets 5Y 16.1% 16.1% 11.1% 11.1% 11.1% 11.1% 10.7% 10.7% 10.7% 10.7% 7.9% 7.9% 7.9% 7.9% 7.3% 7.3% 7.3% 7.3% 6.9% 6.9% 6.86%
Equity 3Y 9.5% 9.5% 8.2% 8.2% 8.2% 8.2% 9.1% 9.1% 9.1% 9.1% 12.4% 12.4% 12.4% 12.4% 11.5% 11.5% 11.5% 11.5% 10.5% 10.5% 10.50%
Book Value 3Y 9.3% 9.3% 8.0% 7.9% 8.0% 8.1% 8.9% 8.7% 8.3% 8.7% 12.2% 12.1% 12.1% 12.1% 11.2% 11.2% 11.1% 11.0% 10.1% 10.2% 10.19%
Dividend 3Y 3.3% 3.2% 3.0% 2.9% 3.1% 3.2% 3.2% 3.0% 2.3% 2.6% 2.5% 2.3% 2.2% 2.1% 2.0% 1.8% 1.6% 1.5% 1.4% 1.5% 1.46%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.94 0.92 0.89 0.90 0.94 0.92 0.90 0.91 0.94 0.93 0.92 0.92 0.98 0.97 0.97 0.98 1.00 1.00 1.00 1.00 1.000
Earnings Stability 0.08 0.06 0.02 0.01 0.04 0.07 0.01 0.03 0.07 0.08 0.00 0.01 0.04 0.07 0.72 0.60 0.80 0.77 0.90 0.81 0.806
Margin Stability 0.96 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.98 0.98 0.97 0.973
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.88 0.97 0.90 0.83 1.00 0.88 0.93 0.88 0.88 0.98 0.86 0.89 0.89 0.84 0.98 0.94 0.94 0.93 0.97 0.93 0.933
Earnings Smoothness 0.74 0.92 0.78 0.65 1.00 0.74 0.83 0.74 0.74 0.95 0.71 0.75 0.76 0.67 0.94 0.84 0.83 0.80 0.92 0.85 0.846
ROE Trend -0.05 -0.07 -0.01 -0.00 -0.00 0.02 0.01 0.04 0.01 0.00 0.03 0.03 0.03 0.03 -0.01 -0.03 -0.03 -0.03 -0.01 -0.01 -0.011
Gross Margin Trend 0.01 0.01 0.01 0.01 0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.021
FCF Margin Trend 0.05 0.04 0.01 -0.01 -0.04 -0.06 -0.07 -0.04 -0.03 -0.02 0.02 0.01 0.01 0.03 0.02 0.03 0.04 0.03 0.02 0.04 0.036
Sustainable Growth Rate 9.1% 7.5% 7.5% 7.4% 7.7% 10.2% 8.3% 9.9% 10.2% 9.3% 11.5% 12.5% 12.9% 13.6% 9.0% 8.3% 8.5% 8.5% 9.1% 9.5% 9.46%
Internal Growth Rate 3.8% 3.1% 3.1% 3.1% 3.2% 4.3% 3.8% 4.5% 4.7% 4.3% 5.6% 6.1% 6.3% 6.6% 4.5% 4.1% 4.2% 4.2% 4.5% 4.7% 4.69%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.63 1.84 1.64 1.50 1.28 1.07 1.11 1.09 1.12 1.23 1.17 1.03 0.99 1.07 1.42 1.50 1.63 1.64 1.55 1.61 1.611
FCF/OCF 0.88 0.86 0.84 0.81 0.78 0.77 0.78 0.79 0.80 0.81 0.85 0.82 0.82 0.83 0.82 0.83 0.84 0.84 0.85 0.85 0.850
FCF/Net Income snapshot only 1.370
OCF/EBITDA snapshot only 0.929
CapEx/Revenue 2.6% 2.9% 3.1% 3.2% 3.4% 3.4% 3.2% 3.2% 3.1% 3.1% 2.8% 2.9% 2.9% 2.9% 3.3% 3.1% 3.1% 3.1% 3.0% 3.2% 3.18%
CapEx/Depreciation snapshot only 0.865
Accruals Ratio -0.04 -0.05 -0.04 -0.03 -0.02 -0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00 0.00 -0.01 -0.03 -0.03 -0.04 -0.05 -0.04 -0.04 -0.045
Sloan Accruals snapshot only -0.026
Cash Flow Adequacy snapshot only 2.553
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 1.0% 1.0% 1.0% 1.0% 1.4% 1.4% 1.2% 1.0% 1.0% 1.1% 1.0% 0.9% 0.9% 0.9% 0.9% 0.9% 0.8% 0.9% 0.9% 1.0% 1.09%
Dividend/Share $2.37 $2.43 $2.48 $2.55 $2.62 $2.68 $2.75 $2.80 $2.85 $2.91 $2.97 $3.01 $3.06 $3.11 $3.16 $3.20 $3.24 $3.28 $3.32 $3.37 $3.44
Payout Ratio 43.5% 48.9% 47.6% 48.3% 48.1% 41.7% 44.6% 40.8% 40.4% 43.2% 36.0% 34.5% 34.2% 33.4% 40.7% 43.2% 42.9% 43.1% 39.6% 39.0% 38.99%
FCF Payout Ratio 30.5% 30.8% 34.7% 39.7% 48.4% 50.9% 51.6% 47.3% 45.3% 43.5% 36.3% 40.6% 42.1% 37.4% 35.0% 34.5% 31.1% 31.1% 30.0% 28.5% 28.46%
Total Payout Ratio 49.1% 55.2% 53.4% 54.9% 54.1% 46.4% 49.7% 46.3% 45.9% 49.2% 40.9% 39.7% 39.2% 38.4% 47.2% 49.6% 49.1% 49.2% 43.6% 39.9% 39.92%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.12 0.12 0.11 0.11 0.12 0.12 0.12 0.11 0.10 0.10 0.09 0.09 0.09 0.08 0.08 0.07 0.07 0.07 0.06 0.06 0.064
Buyback Yield 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.02%
Net Buyback Yield 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.02%
Total Shareholder Return 1.1% 1.1% 1.1% 1.1% 1.5% 1.5% 1.3% 1.1% 1.1% 1.2% 1.1% 1.0% 1.0% 1.0% 1.0% 1.0% 0.9% 1.0% 1.0% 1.0% 1.05%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.84 0.87 0.87 0.88 0.88 0.92 0.88 0.88 0.86 0.81 0.86 0.86 0.86 0.86 0.86 0.86 0.87 0.88 0.72 0.73 0.725
Interest Burden (EBT/EBIT) 1.00 1.00 0.87 0.87 0.88 0.89 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.95 0.95 0.96 0.95 0.948
EBIT Margin 0.15 0.13 0.15 0.15 0.15 0.17 0.15 0.16 0.16 0.16 0.18 0.19 0.19 0.19 0.15 0.14 0.15 0.14 0.19 0.19 0.192
Asset Turnover 0.50 0.52 0.50 0.51 0.51 0.52 0.52 0.53 0.54 0.56 0.53 0.55 0.56 0.57 0.55 0.56 0.57 0.59 0.55 0.56 0.557
Equity Multiplier 2.49 2.49 2.47 2.47 2.47 2.47 2.27 2.27 2.27 2.27 2.18 2.18 2.18 2.18 2.11 2.11 2.11 2.11 2.11 2.11 2.109
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $5.45 $4.96 $5.21 $5.27 $5.44 $6.44 $6.17 $6.86 $7.06 $6.73 $8.24 $8.73 $8.95 $9.31 $7.75 $7.40 $7.55 $7.61 $8.40 $8.63 $8.63
Book Value/Share $34.22 $34.19 $38.87 $38.87 $38.92 $38.97 $43.46 $43.36 $43.28 $43.27 $48.43 $48.28 $48.24 $48.22 $53.44 $53.40 $53.40 $53.36 $58.01 $58.01 $58.23
Tangible Book/Share $-13.73 $-13.71 $-7.53 $-7.53 $-7.54 $-7.55 $-8.24 $-8.22 $-8.20 $-8.20 $-3.24 $-3.23 $-3.23 $-3.22 $0.99 $0.99 $0.99 $0.99 $-6.60 $-6.60 $-6.60
Revenue/Share $42.50 $43.56 $44.70 $45.54 $46.13 $47.01 $48.26 $49.46 $50.68 $51.78 $53.39 $54.44 $55.50 $56.99 $58.52 $60.09 $61.64 $63.05 $64.98 $65.38 $66.00
FCF/Share $7.78 $7.88 $7.15 $6.41 $5.41 $5.28 $5.33 $5.92 $6.30 $6.69 $8.17 $7.42 $7.27 $8.31 $9.03 $9.26 $10.41 $10.53 $11.08 $11.83 $11.94
OCF/Share $8.88 $9.15 $8.53 $7.88 $6.97 $6.86 $6.86 $7.48 $7.88 $8.30 $9.67 $9.01 $8.86 $9.96 $10.99 $11.10 $12.33 $12.50 $13.05 $13.91 $14.04
Cash/Share $7.91 $7.90 $7.89 $7.89 $7.90 $7.91 $5.04 $5.03 $5.02 $5.02 $7.95 $7.93 $7.92 $7.92 $11.64 $11.63 $11.63 $11.62 $10.61 $10.61 $7.74
EBITDA/Share $8.94 $8.28 $9.42 $9.38 $9.58 $10.47 $9.63 $10.41 $10.87 $11.04 $12.25 $12.85 $13.09 $13.55 $11.76 $11.37 $11.93 $12.06 $14.45 $14.97 $14.97
Debt/Share $37.73 $37.69 $33.71 $33.71 $33.75 $33.79 $35.38 $35.30 $35.23 $35.22 $35.15 $35.04 $35.01 $34.99 $36.57 $36.54 $36.54 $36.51 $38.45 $38.45 $38.45
Net Debt/Share $29.82 $29.79 $25.82 $25.82 $25.86 $25.88 $30.34 $30.27 $30.21 $30.20 $27.20 $27.11 $27.09 $27.08 $24.93 $24.91 $24.91 $24.90 $27.84 $27.84 $27.84
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.035
Altman Z-Prime snapshot only 6.881
Piotroski F-Score 7 7 8 7 7 8 7 6 7 7 7 7 6 7 7 7 7 7 7 7 7
Beneish M-Score -2.49 -2.64 -2.56 -2.51 -2.43 -2.36 -2.29 -2.32 -2.35 -2.40 -2.51 -2.44 -2.43 -2.45 -2.56 -2.60 -2.63 -2.65 -2.60 -2.61 -2.614
Ohlson O-Score snapshot only -8.885
Net-Net WC snapshot only $-27.60
EVA snapshot only $594369782.61
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 77.35 76.64 82.53 80.92 78.90 78.86 80.25 78.65 79.52 78.85 82.13 81.63 82.10 81.65 81.59 81.42 83.91 81.18 78.38 79.03 79.029
Credit Grade snapshot only 5
Credit Trend snapshot only -2.393
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 73
Sector Credit Rank snapshot only 77

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms